Balaji S, Rao A, Saraswathi K, Sethu Nagarajan R, Santhi R, Kim U
Med Oncol. 2024; 41(7):168.
PMID: 38834895
DOI: 10.1007/s12032-024-02391-9.
Candido M, Medeiros M, Veronez L, Bastos D, Oliveira K, Pezuk J
Pharmaceutics. 2023; 15(2).
PMID: 36839989
PMC: 9966033.
DOI: 10.3390/pharmaceutics15020664.
Chen M, Zhao Z, Wu L, Huang J, Yu P, Qian J
Cell Death Dis. 2022; 13(9):784.
PMID: 36096885
PMC: 9468144.
DOI: 10.1038/s41419-022-05222-9.
Gu L, Ma G, Li C, Lin J, Zhao G
Front Oncol. 2022; 12:958170.
PMID: 36003786
PMC: 9393514.
DOI: 10.3389/fonc.2022.958170.
Babu V, Mallipatna A, Sa D, Dudeja G, Kannan R, Shetty R
Cells. 2022; 11(10).
PMID: 35626705
PMC: 9139581.
DOI: 10.3390/cells11101668.
Genome maintenance in retinoblastoma: Implications for therapeutic vulnerabilities.
Lee C, Kim J
Oncol Lett. 2022; 23(6):192.
PMID: 35527780
PMC: 9073582.
DOI: 10.3892/ol.2022.13312.
Identification of Epigenetically Modified Hub Genes and Altered Pathways Associated With Retinoblastoma.
Karmakar A, Khan M, Kumari N, Devarajan N, Ganesan S
Front Cell Dev Biol. 2022; 10:743224.
PMID: 35359459
PMC: 8960645.
DOI: 10.3389/fcell.2022.743224.
PRAMEF2-mediated dynamic regulation of YAP signaling promotes tumorigenesis.
Ghosh M, Das S
Proc Natl Acad Sci U S A. 2021; 118(40).
PMID: 34593639
PMC: 8501796.
DOI: 10.1073/pnas.2105523118.
Ubiquitin specific peptidase 33 promotes cell proliferation and reduces apoptosis through regulation of the SP1/PI3K/AKT pathway in retinoblastoma.
Wang H, Liu Z, Sun Z, Zhou D, Mao H, Deng G
Cell Cycle. 2021; 20(19):2066-2076.
PMID: 34470581
PMC: 8565810.
DOI: 10.1080/15384101.2021.1970305.
Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy.
Sabo A, Dudau M, Constantin G, Pop T, Geilfus C, Naccarati A
Front Pharmacol. 2021; 12:652074.
PMID: 34295245
PMC: 8290364.
DOI: 10.3389/fphar.2021.652074.
Adhesion G protein-coupled receptor, ELTD1, is a potential therapeutic target for retinoblastoma migration and invasion.
Guihurt Santiago J, Burgos-Tirado N, Lafontaine D, Mendoza Sierra J, Camacho R, Vecchini Rodriguez C
BMC Cancer. 2021; 21(1):53.
PMID: 33430814
PMC: 7802354.
DOI: 10.1186/s12885-020-07768-3.
Chromatin regulators in retinoblastoma: Biological roles and therapeutic applications.
Lee C, Kim J
J Cell Physiol. 2020; 236(4):2318-2332.
PMID: 32840881
PMC: 7891620.
DOI: 10.1002/jcp.30022.
Retinoblastoma: Etiology, Modeling, and Treatment.
Kaewkhaw R, Rojanaporn D
Cancers (Basel). 2020; 12(8).
PMID: 32824373
PMC: 7465685.
DOI: 10.3390/cancers12082304.
Bioinformatics analyses of retinoblastoma reveal the retinoblastoma progression subtypes.
Cao M, Wang S, Zou J, Wang W
PeerJ. 2020; 8:e8873.
PMID: 32509443
PMC: 7246025.
DOI: 10.7717/peerj.8873.
Discovery of a transcriptomic core of genes shared in 8 primary retinoblastoma with a novel detection score analysis.
Alvarez-Suarez D, Tovar H, Hernandez-Lemus E, Orjuela M, Sadowinski-Pine S, Cabrera-Munoz L
J Cancer Res Clin Oncol. 2020; 146(8):2029-2040.
PMID: 32474753
DOI: 10.1007/s00432-020-03266-y.
Downregulation of microRNA-224-3p Hampers Retinoblastoma Progression via Activation of the Hippo-YAP Signaling Pathway by Increasing LATS2.
Song L, Huang Y, Zhang X, Han S, Hou M, Li H
Invest Ophthalmol Vis Sci. 2020; 61(3):32.
PMID: 32186675
PMC: 7401717.
DOI: 10.1167/iovs.61.3.32.
Biomarkers in retinoblastoma.
Sun J, Xi H, Shao Q, Liu Q
Int J Ophthalmol. 2020; 13(2):325-341.
PMID: 32090044
PMC: 7013786.
DOI: 10.18240/ijo.2020.02.18.
Overexpression of Biglycan is Associated with Resistance to Rapamycin in Human WERI-Rb-1 Retinoblastoma Cells by Inducing the Activation of the Phosphatidylinositol 3-Kinases (PI3K)/Akt/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
Fang D, Lai Z, Wang Y
Med Sci Monit. 2019; 25:6639-6648.
PMID: 31483776
PMC: 6743380.
DOI: 10.12659/MSM.915075.
Investigation of new candidate genes in retinoblastoma using the TruSight One "clinical exome" gene panel.
Akdeniz D, Tuncer S, Kebudi R, Celik B, Kuru G, Kilic S
Mol Genet Genomic Med. 2019; 7(8):e785.
PMID: 31207142
PMC: 6687622.
DOI: 10.1002/mgg3.785.
Circular RNAs: Novel Promising Biomarkers in Ocular Diseases.
Guo N, Liu X, Pant O, Zhou D, Hao J, Lu C
Int J Med Sci. 2019; 16(4):513-518.
PMID: 31171902
PMC: 6535655.
DOI: 10.7150/ijms.29750.